VIVEbiotech participates in the 26th annual congress of the ESGCT that took place in Lausanne

VIVEbiotech has participated in the 26th Congress of the European Society of Gene and Cell Therapy (ESGCT) that took place in Lausanne, Switzerland, on 16, 17, 18 and 19 October. It was a collaborative conference between the ESGCT, the ISSCR (International Society for Stem Cell Research) and the SFTCG (Société Française de Thérapie Cellulaire et Génique).

In this congress, the latest research and techniques in the fields of gene and cell therapy are highlighted annually through its scientific sessions. These sessions include lectures and posters in which renowned speakers participate. In addition, the congress is an opportunity to develop relationships and collaborations.

During this event the Business Development Director of VIVEbiotech Dr. Natalia Elizalde has attended a stand in which she held many meetings. She publicized both the services that VIVEbiotech offers in the field of gene therapy with the production of lentiviral vectors, as well as the own technologies that we develop, technologies as Lentisoma.

Contact us

Mikeletegi Pasealekua 81, San Sebastián 20009, Gipuzkoa (SPAIN)